281 related articles for article (PubMed ID: 20035013)
1. Loss of nuclear poly(A)-binding protein 1 causes defects in myogenesis and mRNA biogenesis.
Apponi LH; Leung SW; Williams KR; Valentini SR; Corbett AH; Pavlath GK
Hum Mol Genet; 2010 Mar; 19(6):1058-65. PubMed ID: 20035013
[TBL] [Abstract][Full Text] [Related]
2. Functional impact of an oculopharyngeal muscular dystrophy mutation in PABPN1.
García-Castañeda M; Vega AV; Rodríguez R; Montiel-Jaen MG; Cisneros B; Zarain-Herzberg A; Avila G
J Physiol; 2017 Jul; 595(13):4167-4187. PubMed ID: 28303574
[TBL] [Abstract][Full Text] [Related]
3. Cytoplasmic targeting of mutant poly(A)-binding protein nuclear 1 suppresses protein aggregation and toxicity in oculopharyngeal muscular dystrophy.
Abu-Baker A; Laganiere S; Fan X; Laganiere J; Brais B; Rouleau GA
Traffic; 2005 Sep; 6(9):766-79. PubMed ID: 16101680
[TBL] [Abstract][Full Text] [Related]
4. HnRNP A1 and A/B interaction with PABPN1 in oculopharyngeal muscular dystrophy.
Fan X; Messaed C; Dion P; Laganiere J; Brais B; Karpati G; Rouleau GA
Can J Neurol Sci; 2003 Aug; 30(3):244-51. PubMed ID: 12945950
[TBL] [Abstract][Full Text] [Related]
5. Nuclear entrapment and extracellular depletion of PCOLCE is associated with muscle degeneration in oculopharyngeal muscular dystrophy.
Raz V; Sterrenburg E; Routledge S; Venema A; van der Sluijs BM; Trollet C; Dickson G; van Engelen BG; van der Maarel SM; Antoniou MN
BMC Neurol; 2013 Jul; 13():70. PubMed ID: 23815790
[TBL] [Abstract][Full Text] [Related]
6. Nuclear poly(A) binding protein 1 (PABPN1) and Matrin3 interact in muscle cells and regulate RNA processing.
Banerjee A; Vest KE; Pavlath GK; Corbett AH
Nucleic Acids Res; 2017 Oct; 45(18):10706-10725. PubMed ID: 28977530
[TBL] [Abstract][Full Text] [Related]
7. Assessment of PABPN1 nuclear inclusions on a large cohort of patients and in a human xenograft model of oculopharyngeal muscular dystrophy.
Roth F; Dhiab J; Boulinguiez A; Mouigni HR; Lassche S; Negroni E; Muraine L; Marhic A; Oliver A; Lainé J; Rouche A; O'Ferrall EK; van Engelen B; Ottenheijm C; Greif H; Blumen S; Lacau St Guily J; Perie S; Butler-Browne G; Mouly V; Trollet C
Acta Neuropathol; 2022 Dec; 144(6):1157-1170. PubMed ID: 36197469
[TBL] [Abstract][Full Text] [Related]
8. Control of mRNA stability contributes to low levels of nuclear poly(A) binding protein 1 (PABPN1) in skeletal muscle.
Apponi LH; Corbett AH; Pavlath GK
Skelet Muscle; 2013 Oct; 3(1):23. PubMed ID: 24083404
[TBL] [Abstract][Full Text] [Related]
9. In vivo aggregation properties of the nuclear poly(A)-binding protein PABPN1.
Tavanez JP; Calado P; Braga J; Lafarga M; Carmo-Fonseca M
RNA; 2005 May; 11(5):752-62. PubMed ID: 15811916
[TBL] [Abstract][Full Text] [Related]
10. Depletion of nuclear poly(A) binding protein PABPN1 produces a compensatory response by cytoplasmic PABP4 and PABP5 in cultured human cells.
Bhattacharjee RB; Bag J
PLoS One; 2012; 7(12):e53036. PubMed ID: 23300856
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial dysfunction reveals the role of mRNA poly(A) tail regulation in oculopharyngeal muscular dystrophy pathogenesis.
Chartier A; Klein P; Pierson S; Barbezier N; Gidaro T; Casas F; Carberry S; Dowling P; Maynadier L; Bellec M; Oloko M; Jardel C; Moritz B; Dickson G; Mouly V; Ohlendieck K; Butler-Browne G; Trollet C; Simonelig M
PLoS Genet; 2015 Mar; 11(3):e1005092. PubMed ID: 25816335
[TBL] [Abstract][Full Text] [Related]
12. PABPN1: molecular function and muscle disease.
Banerjee A; Apponi LH; Pavlath GK; Corbett AH
FEBS J; 2013 Sep; 280(17):4230-50. PubMed ID: 23601051
[TBL] [Abstract][Full Text] [Related]
13. Oligomerization of polyalanine expanded PABPN1 facilitates nuclear protein aggregation that is associated with cell death.
Fan X; Dion P; Laganiere J; Brais B; Rouleau GA
Hum Mol Genet; 2001 Oct; 10(21):2341-51. PubMed ID: 11689481
[TBL] [Abstract][Full Text] [Related]
14. Novel mouse models of oculopharyngeal muscular dystrophy (OPMD) reveal early onset mitochondrial defects and suggest loss of PABPN1 may contribute to pathology.
Vest KE; Phillips BL; Banerjee A; Apponi LH; Dammer EB; Xu W; Zheng D; Yu J; Tian B; Pavlath GK; Corbett AH
Hum Mol Genet; 2017 Sep; 26(17):3235-3252. PubMed ID: 28575395
[TBL] [Abstract][Full Text] [Related]
15. Poly(A) binding protein nuclear 1 levels affect alternative polyadenylation.
de Klerk E; Venema A; Anvar SY; Goeman JJ; Hu O; Trollet C; Dickson G; den Dunnen JT; van der Maarel SM; Raz V; 't Hoen PA
Nucleic Acids Res; 2012 Oct; 40(18):9089-101. PubMed ID: 22772983
[TBL] [Abstract][Full Text] [Related]
16. Nuclear speckles are involved in nuclear aggregation of PABPN1 and in the pathophysiology of oculopharyngeal muscular dystrophy.
Bengoechea R; Tapia O; Casafont I; Berciano J; Lafarga M; Berciano MT
Neurobiol Dis; 2012 Apr; 46(1):118-29. PubMed ID: 22249111
[TBL] [Abstract][Full Text] [Related]
17. PABPN1 polyalanine tract deletion and long expansions modify its aggregation pattern and expression.
Klein AF; Ebihara M; Alexander C; Dicaire MJ; Sasseville AM; Langelier Y; Rouleau GA; Brais B
Exp Cell Res; 2008 May; 314(8):1652-66. PubMed ID: 18367172
[TBL] [Abstract][Full Text] [Related]
18. Ectopic expression of a polyalanine expansion mutant of poly(A)-binding protein N1 in muscle cells in culture inhibits myogenesis.
Wang Q; Bag J
Biochem Biophys Res Commun; 2006 Feb; 340(3):815-22. PubMed ID: 16378590
[TBL] [Abstract][Full Text] [Related]
19. A Drosophila model of oculopharyngeal muscular dystrophy reveals intrinsic toxicity of PABPN1.
Chartier A; Benoit B; Simonelig M
EMBO J; 2006 May; 25(10):2253-62. PubMed ID: 16642034
[TBL] [Abstract][Full Text] [Related]
20. Proteomic analysis reveals that wildtype and alanine-expanded nuclear poly(A)-binding protein exhibit differential interactions in skeletal muscle.
Banerjee A; Phillips BL; Deng Q; Seyfried NT; Pavlath GK; Vest KE; Corbett AH
J Biol Chem; 2019 May; 294(18):7360-7376. PubMed ID: 30837270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
